Bruno Ledergerber

26.5k citations

224 papers · 16.2k indexed · 6 hit papers · h-index 62

Impact in

Virology top 0.02%
- HIV Research and Treatment
Infectious Diseases top 0.02%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment

Papers in

Virology 117
- HIV Research and Treatment 117
Infectious Diseases 165
- HIV/AIDS Research and Interventions 120
- HIV/AIDS drug development and treatment 116

Co-authors: Jens Lundgren Rainer Weber Matthias Egger Hansjakob Furrer Amanda Mocroft Bernard Hirschel Ole Kirk Enos Bernasconi
Journals: AIDS (30 papers)Clinical Infectious Diseases (21 papers)The Journal of Infectious Diseases (19 papers)HIV Medicine (17 papers)PLoS ONE (14 papers)
Partner nations: Switzerland United Kingdom Denmark

In The Last Decade

Bruno Ledergerber

222 papers receiving 15.7k citations

Hit Papers

6 papers align trajectories log scale

Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals 2012 · 419 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 PLoS ONE
2011 Clinical Infectious Diseases
2008 PLoS Medicine
2003 The Lancet
2002 The Lancet
1999 The Lancet

Peers

Countries citing papers authored by Bruno Ledergerber

Since Specialization

Citations

This map shows the geographic impact of Bruno Ledergerber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Ledergerber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Ledergerber more than expected).

Fields of papers citing papers by Bruno Ledergerber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Ledergerber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Ledergerber. The network helps show where Bruno Ledergerber may publish in the future.

Co-authors

The 25 scholars most cited alongside Bruno Ledergerber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bruno Ledergerber Line = papers co-authored together Bruno Ledergerber links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Dismal prognosis of patients with operative indication without surgical intervention in active left-sided infective endocarditis Frontiers in Cardiovascular Medicine ·Alix Zorrillo Rodríguez, Juri Sromicki, Michelle Frank, Matthias Greutmann, Bruno Ledergerber, Masood Feyzbakhsh Rankooh, Laura Alonso, Paul Vogt, Thierry Carrel, Omer Dzemali, Carlos A. Mestres, Barbara Hasse	2023	6
2	Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years The Lancet Healthy Longevity ·Mathieu van der Jagt, Andrés Esteban-Cantos, Christian Thorball, Berta Rodés, Peter Reiss, Javier Rodríguez-Centeno, Kouich Imamura, Dominique L. Braun, Catia Marzolini, Gabriel Franco de Sousa, Enos Bernasconi, Matthias Cavassini, K. Manns, Maria Christine Thurnheer, Roger D. Kouyos, Jacques Fellay, Huldrych F. Günthard, José Ramón Arribas, Bruno Ledergerber, Philip Tarr	2023	21
3	Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH study BMJ Open ·Christine Sekaggya‐Wiltshire, Barbara Castelnuovo, Amrei von Braun, Joseph Musaazi, Daniel J. Müller, Allan Buzibye, Ursula Gutteck, Lars Henning, Bruno Ledergerber, Natascia Corti, Mohammed Lamorde, Jan Fehr, Andrew Kambugu	2017	8
4	Reasons for not starting antiretroviral therapy in HIV-1-infected individuals: a changing landscape Infection ·Jan Fehr, Dunja Nicca, Jean‐Christophe Goffard, David Haerry, Michael Schlag, Vasileios Papastamopoulos, Andy I. M. Hoepelman, J. Rick Turner, Gauranvi, Bruno Ledergerber	2016	6
5	Dynamic versus marginal structural models for estimating the effect of HAART on CD4 in observational studies : application to the Aquitaine Cohort study and the Swiss HIV Cohort Study arXiv (Cornell University) ·Mélanie Prague, Daniel Commenges, 柳宗万, Bruno Ledergerber, Jim Young, Hansjakob Furrer, Rodolphe Thiébaut	2015	1
6	A sequential Cox approach for estimating the causal effect of treatment in the presence of time‐dependent confounding applied to data from the Swiss HIV Cohort Study Statistics in Medicine ·Jon Michael Gran, Kjetil Røysland, Marcel Wolbers, Vanessa Didelez, Jonathan A C Sterne, Bruno Ledergerber, Hansjakob Furrer, Viktor von Wyl, Odd O. Aalen	2010	60
7	Epidemiological and Biological Evidence for a Compensatory Effect of Connection Domain Mutation N348I on M184V in HIV‐1 Reverse Transcriptase The Journal of Infectious Diseases ·Viktor von Wyl, Maryam Ehteshami, Jori Symons, Philippe Bürgisser, Monique Nijhuis, Lisa M. Demeter, Sabine Yerly, Jürg Böni, Thomas Klimkait, Rob Schuurman, Bruno Ledergerber, Matthias Götte, Huldrych F. Günthard, (unknown)	2010	23
8	Hepatitis C Virus Coinfection Does Not Influence the CD4 Cell Recovery in HIV-1-Infected Patients With Maximum Virologic Suppression JAIDS Journal of Acquired Immune Deficiency Syndromes ·Lars Peters, Amanda Mocroft, Vincent Soriano, Jürgen K. Rockstroh, Marcelo Losso, Laure Valério, Pauls Aldiņš, Peter Reiss, Bruno Ledergerber, Jens Lundgren	2009	34
9	Effect of atazanavir versus other protease inhibitor-containing antiretroviral therapy on endothelial function in HIV-infected persons: randomised controlled trial Heart ·Andreas J. Flammer, E. B. Labohm, Bruno Ledergerber, Matthias Hermann, Andrzej Biedermann, Angela Huttner, J. Evison, Iris Baumgärtner, Matthias Cavassini, Daniel Hayoz, Kurt Quitzau, Martin Hersberger, Isabella Sudano, Frank Ruschitzka, Thomas F. Lüscher, G. Noll, Rachel Weber	2008	37
10	Spontaneous Viral Clearance, Viral Load, and Genotype Distribution of Hepatitis C Virus (HCV) in HIV‐Infected Patients with Anti‐HCV Antibodies in Europe The Journal of Infectious Diseases ·Vincent Soriano, Amanda Mocroft, V. T. Koftelev, Bruno Ledergerber, Brygida Knysz, Saulius Chaplinskas, Lars Peters, Anders Karlsson, Christine Katlama, Carlos Toro, Bernd Kupfer, Martin Vogel, Jens Lundgren, (unknown)	2008	131
11	Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection PLoS Medicine ·Lewis H. Kuller, Russell P. Tracy, Waldo Belloso, Stéphane De Wit, Fraser Drummond, H. Clifford Lane, Bruno Ledergerber, Jens Lundgren, Jacqueline Neuhaus, Daniel E. Nixon, Nicholas I. Paton, James D. Neaton, (unknown) Hit paper breakdown →	2008	1231
12	Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/ L in HIV Type 1--Infected Individuals Receiving Potent Antiretroviral Therapy Clinical Infectious Diseases ·Gilbert R. Kaufmann, H Furrer, Bruno Ledergerber, Lionel Perrin, Milos Opravil, P Vernazza, Matthias Cavassini, Enos Bernasconi, Martin Rickenbach, Bernard Hirschel, M Battegay, (unknown)	2005	245
13	Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppression AIDS ·Andrew Phillips, Bruno Ledergerber, Andrzej Horban, Peter Reiss, Antonio Chiesi, Ole Kirk, Fiona Mulcahy, Martin Fisher, Ladislav Machala, Jens Lundgren	2004	25
14	Causes of death in HIV infection AIDS ·Amanda Mocroft, José M. Gatell, Peter Reiss, Bruno Ledergerber, Ole Kirk, Stefano Vella, Anders Blaxhult, Andrew Phillips, Jens Lundgren	2004	30
15	Antiretroviral Treatment and Osteonecrosis in Patients of the Swiss HIV Cohort Study: A Nested Case-Control Study AIDS Research and Human Retroviruses ·Barbara Hasse, Bruno Ledergerber, Matthias Egger, Markus Flepp, Stefano P. Bachmann, Enos Bernasconi, David Kuperstein, Bernard Hirschel, Rainer Weber, Huldrych F. Günthard	2004	24
16	Virological rebound after suppression on highly active antiretroviral therapy AIDS ·Amanda Mocroft, Lı́dia Ruiz, Peter Reiss, Bruno Ledergerber, Christine Katlama, Adriano Lazzarin, Dong Kee Kim, Andrew Phillips, Bonaventura Clotet, Jens Lundgren	2003	91
17	Switching from protease inhibitors to efavirenz: differences in efficacy and tolerance among risk groups: a case–control study from the Swiss HIV Cohort AIDS ·Bernard Hirschel, Markus Flepp, Heiner C. Bucher, B. Powers, Amalio Telenti, Thomas Wagels, Enos Bernasconi, Bruno Ledergerber	2002	21
18	Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy AIDS ·Gilbert Greub, Alessandro Cozzi‐Lepri, Bruno Ledergerber, Schlomo Staszewski, Luc Perrin, Veronica Miller, P Francioli, Hansjakob Furrer, Manuel Battegay, Pietro Vernazza, Enos Bernasconi, Huldrych F. Günthard, Bernard Hirschel, Andrew Phillips, Amalio Telenti	2002	95
19	Viral toad changes in response to antiretroviral therapy according to the baseline CD4 lymphocyte count and viral load UCL Discovery (University College London) ·AN Phillips, S Staszewski, Rainer Weber, Ole Kirk, P Francioli, Miller, Pietro Vernazza, Jens Lundgren, Bruno Ledergerber	2000	3
20	Tuberculosis among European patients with the acquired immune deficiency syndrome Tubercle and Lung Disease ·Philippe Sudre, Bernard Hirschel, Josep M. Gatell, Stephan Schwander, Stefano Vella, Christine Katlama, Bruno Ledergerber, Antonella d’Arminio Monforte, Frank-Detlef Goebel, Ilias Mastoris, C Pedersen, Jens Lundgren	1996	21

About Bruno Ledergerber

Bruno Ledergerber is a scholar working on Virology, Infectious Diseases, Emergency Medicine, Hepatology and Applied Microbiology and Biotechnology, having authored 224 papers that have together received 16.2k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (120 papers), HIV Research and Treatment (117 papers), HIV/AIDS drug development and treatment (116 papers), HIV-related health complications and treatments (60 papers), Pneumocystis jirovecii pneumonia detection and treatment (26 papers), Hepatitis C virus research (26 papers), HIV, Drug Use, Sexual Risk (20 papers) and Liver Disease Diagnosis and Treatment (11 papers). The work is most often cited by research in Virology (7.6k citations), Infectious Diseases (11.1k citations), Emergency Medicine (5.0k citations), Hepatology (1.6k citations) and Epidemiology (5.8k citations). Bruno Ledergerber has collaborated with scholars based in Switzerland, United Kingdom and Denmark. Frequent co-authors include Jens Lundgren, Rainer Weber, Matthias Egger, Hansjakob Furrer, Amanda Mocroft, Bernard Hirschel, Ole Kirk, Enos Bernasconi, Peter Reiss and Pietro Vernazza. Their work appears in journals such as AIDS, Clinical Infectious Diseases, The Journal of Infectious Diseases, HIV Medicine and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact